These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1983066)

  • 1. Characterization of the inhibitory 5-HT receptor in the rat vas deferens.
    Smith CF; Bennett RT
    Arch Int Pharmacodyn Ther; 1990; 308():76-85. PubMed ID: 1983066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
    Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ethanol on rat vas deferens.
    Wali FA; Hayter A
    Acta Physiol Hung; 1989; 74(3-4):201-7. PubMed ID: 2640403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptors in the mouse vas deferens.
    Smith CF; Rowland PB
    Arch Int Pharmacodyn Ther; 1989; 299():144-54. PubMed ID: 2774764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
    Wurch T; Palmier C; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonist activity of 8-OH-DPAT.
    Smith CF; Cutts S
    Arch Int Pharmacodyn Ther; 1990; 306():106-13. PubMed ID: 1981664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain.
    Maura G; Ulivi M; Raiteri M
    Neuropharmacology; 1987 Jul; 26(7A):713-7. PubMed ID: 3627379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.
    Chaput Y; Lesieur P; de Montigny C
    Synapse; 1990; 6(4):328-37. PubMed ID: 1962911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin potentiates the prejunctional inhibitory effect of 5-hydroxytryptamine on rat vas deferens.
    Moritoki H; Fukuda H; Kanaya J; Ishida Y
    J Pharm Pharmacol; 1986 Oct; 38(10):737-41. PubMed ID: 2878993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens.
    Borton M; Docherty JR
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):130-5. PubMed ID: 2234097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists.
    Middlemiss DN
    Eur J Pharmacol; 1986 Jan; 120(1):51-6. PubMed ID: 2868904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
    Karasawa A; Kubo K; Shuto K; Nakamizo N
    Jpn J Pharmacol; 1985 Mar; 37(3):285-91. PubMed ID: 3158769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.